SHARP PHILIP A
Insider CIK 1226295 · ALNY Director · SYRS Director · VIR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-01-23 | 2025-01-24 | 11,250 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-01-23 | 2025-01-24 | 11,250 | $131.21 | $1.48M | 11,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-01-23 | 2025-01-24 | 11,250 | $275.00 | $3.09M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-05-16 | 2024-05-20 | 5,228 | — | $0 | 5,228 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-02-29 | 2024-03-01 | 30,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-29 | 2024-03-01 | 101 | $154.07 | $15.6K | 516 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-29 | 2024-03-01 | 1,906 | $153.62 | $292.8K | 617 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-02-29 | 2024-03-01 | 30,000 | $59.25 | $1.78M | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-29 | 2024-03-01 | 13,005 | $150.60 | $1.96M | 16,995 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-29 | 2024-03-01 | 13,557 | $151.43 | $2.05M | 3,438 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-29 | 2024-03-01 | 516 | $156.54 | $80.8K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-29 | 2024-03-01 | 915 | $152.40 | $139.4K | 2,523 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2023-05-22 | 2023-05-24 | 12,054 | — | $0 | 12,054 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2023-05-22 | 2023-05-24 | 6,027 | — | $0 | 121,174 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-05-18 | 2023-05-19 | 3,454 | — | $0 | 3,454 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2022-08-15 | 2022-08-17 | 30,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2022-08-15 | 2022-08-17 | 3,670 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-15 | 2022-08-17 | 1,218 | $228.33 | $278.1K | 32,354 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-15 | 2022-08-17 | 98 | $226.16 | $22.2K | 33,572 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-15 | 2022-08-17 | 3,853 | $231.65 | $892.5K | 715 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2022-08-15 | 2022-08-17 | 30,000 | $30.09 | $902.7K | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-15 | 2022-08-17 | 715 | $232.81 | $166.5K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-15 | 2022-08-17 | 11,600 | $229.93 | $2.67M | 20,754 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-15 | 2022-08-17 | 16,186 | $230.71 | $3.73M | 4,568 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2022-08-15 | 2022-08-17 | 3,670 | $63.86 | $234.4K | 33,670 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2022-05-23 | 2022-05-25 | 12,810 | — | $0 | 12,810 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2022-05-23 | 2022-05-25 | 6,405 | — | $0 | 115,147 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-05-18 | 2022-05-20 | 5,153 | — | $0 | 5,153 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2022-02-09 | 2022-02-11 | 30,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-02-09 | 2022-02-11 | 30,000 | $150.00 | $4.50M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2022-02-09 | 2022-02-11 | 30,000 | $11.33 | $339.9K | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-07-15 | 2021-07-19 | 4,032 | — | $0 | 4,032 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2021-05-21 | 2021-05-25 | 6,748 | — | $0 | 6,748 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2021-05-21 | 2021-05-25 | 3,374 | — | $0 | 108,742 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2020-12-07 | 2020-12-22 | 235,633 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2020-12-07 | 2020-12-22 | 235,633 | — | $0 | 266,899 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-11-25 | 2020-11-30 | 30,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-11-25 | 2020-11-30 | 2,117 | $126.16 | $267.1K | 236,278 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-11-25 | 2020-11-30 | 15,715 | $125.05 | $1.97M | 238,395 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-11-25 | 2020-11-30 | 645 | $127.44 | $82.2K | 235,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-11-25 | 2020-11-30 | 30,000 | $9.30 | $279.0K | 265,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-11-25 | 2020-11-30 | 11,523 | $124.30 | $1.43M | 254,110 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-07-01 | 2020-07-06 | 4,581 | — | $0 | 4,581 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-06-11 | 2020-06-11 | 17,500 | — | $0 | 17,500 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-05-21 | 2020-10-13 | 24,850 | — | $0 | 24,850 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 28,888 | — | $0 | 28,888 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-02-12 | 2020-02-13 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-02-12 | 2020-02-13 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-02-12 | 2020-02-13 | 15,000 | $15.82 | $237.3K | 250,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-02-12 | 2020-02-13 | 15,000 | $9.14 | $137.1K | 265,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-12 | 2020-02-13 | 30,000 | $130.00 | $3.90M | 235,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-11-18 | 2019-11-20 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-11-18 | 2019-11-20 | 15,000 | $16.43 | $246.4K | 250,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-11-18 | 2019-11-20 | 5,559 | $91.17 | $506.8K | 245,074 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-11-18 | 2019-11-20 | 8,631 | $91.97 | $793.8K | 236,443 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-11-18 | 2019-11-20 | 810 | $92.66 | $75.1K | 235,633 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 44,444 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 88,888 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 44,444 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 44,444 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 44,444 | — | $0 | 44,444 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 44,444 | — | $0 | 44,444 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 44,444 | — | $0 | 44,444 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 88,888 | — | $0 | 105,368 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2019-10-10 | 2019-10-11 | 22,222 | — | $0 | 22,222 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-07-01 | 2019-07-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-06-11 | 2019-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-04-15 | 2019-04-17 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-04-15 | 2019-04-17 | 11,800 | $87.86 | $1.04M | 238,833 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-04-15 | 2019-04-17 | 600 | $91.40 | $54.8K | 235,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-04-15 | 2019-04-17 | 15,000 | $22.09 | $331.4K | 250,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-04-15 | 2019-04-17 | 2,200 | $89.03 | $195.9K | 236,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-04-15 | 2019-04-17 | 400 | $89.97 | $36.0K | 236,233 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-06-20 | 2018-06-22 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-06-14 | 2018-06-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-13 | 2018-03-14 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-13 | 2018-03-14 | 15,000 | $149.00 | $2.23M | 140,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-13 | 2018-03-14 | 15,000 | $21.35 | $320.3K | 155,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-09 | 2018-03-13 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-09 | 2018-03-13 | 15,000 | $27.28 | $409.2K | 155,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-09 | 2018-03-13 | 15,000 | $129.00 | $1.94M | 140,795 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-09-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-06-02 | 2017-06-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-02-01 | 2017-02-03 | 25,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-02-01 | 2017-02-03 | 20,171 | $39.72 | $801.2K | 145,624 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-02-01 | 2017-02-03 | 25,000 | $31.29 | $782.3K | 165,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-02-01 | 2017-02-03 | 4,829 | $40.16 | $193.9K | 140,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-01-25 | 2017-01-27 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-01-25 | 2017-01-27 | 15,000 | $37.95 | $569.3K | 140,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-01-25 | 2017-01-27 | 15,000 | $31.39 | $470.9K | 155,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-01-18 | 2017-01-20 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-01-18 | 2017-01-20 | 6,200 | $38.20 | $236.8K | 140,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-01-18 | 2017-01-20 | 15,000 | $15.91 | $238.7K | 155,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-01-18 | 2017-01-20 | 8,800 | $37.57 | $330.6K | 146,995 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2016-09-15 | 2016-09-19 | 22,000 | — | $0 | 22,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-06 | 150,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-06 | 550,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-06 | 150,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-06 | 150,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-06 | 146,666 | — | $0 | 146,666 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-06-03 | 2016-06-07 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-12-04 | 2015-12-04 | 10,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-12-04 | 2015-12-04 | 20,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-12-04 | 2015-12-04 | 20,000 | $14.05 | $281.0K | 170,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-12-04 | 2015-12-04 | 30,000 | $109.00 | $3.27M | 140,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-12-04 | 2015-12-04 | 10,000 | $14.74 | $147.4K | 150,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-06-01 | 2015-06-03 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2015-06-01 | 2015-06-03 | 25,844 | — | $0 | 140,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2015-06-01 | 2015-06-03 | 25,844 | — | $0 | 126,104 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-10-13 | 2014-10-15 | 100,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-10-13 | 2014-10-15 | 10,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-10-13 | 2014-10-15 | 100,000 | $7.77 | $777.0K | 174,996 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-10-13 | 2014-10-15 | 10,000 | $7.08 | $70.8K | 184,996 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-10-13 | 2014-10-15 | 110,000 | $85.00 | $9.35M | 74,996 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2014-07-09 | 2014-10-15 | 21,890 | — | $0 | 191,903 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2014-07-09 | 2014-10-15 | 21,890 | — | $0 | 74,996 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-06-05 | 2014-06-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-01-02 | 2014-01-03 | 3,670 | — | $0 | 3,670 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2013-07-02 | 2014-01-03 | 27,325 | — | $0 | 41,594 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2013-07-02 | 2014-01-03 | 11,512 | — | $0 | 213,793 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2013-07-02 | 2014-01-03 | 27,325 | — | $0 | 225,305 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2013-07-02 | 2014-01-03 | 11,512 | — | $0 | 53,106 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-06-06 | 2013-06-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2013-01-22 | 2013-01-24 | 4,967 | $20.13 | $100.0K | 14,269 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2012-06-21 | 2012-06-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2012-02-21 | 2012-02-23 | 9,302 | $10.75 | $100.0K | 9,302 | SEC↗ |